Life Edit Therapeutics
Adrianne Pittman has extensive experience in laboratory management and research, currently serving as the Lab Operations Manager at Life Edit Therapeutics since November 2021. Prior to this role, Adrianne spent over 16 years at Duke University, where responsibilities included Research Lab Manager, Research Associate, and Associate in Research. Earlier in Adrianne's career, work as a Senior Lab Technician took place at Syngenta from 2003 to 2005. Adrianne holds a Bachelor's Degree in Biology from the University of North Carolina at Chapel Hill.
Life Edit Therapeutics
Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.